Lehrstuhl für Innere Medizin III


close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Unveiling Metabolic Similarities of Entheses in Patients with Psoriasis and Psoriatic Arthritis Using Noninvasive In Vivo Molecular Imaging: Results From a Cross-sectional Exploratory Study (2024) Fagni F, Tascilar K, Noversa de Sousa R, Bayat S, Sollfrank L, Kleyer A, Sticherling M, et al. Journal article Metabolic profiling of single cells by exploiting NADH and FAD fluorescence via flow cytometry (2024) Abir AH, Weckwerth L, Wilhelm A, Thomas J, Reichardt C, Munoz LE, Völkl S, et al. Journal article, Original article Comparison of Two Symptom Checkers (Ada and Symptoma) in the Emergency Department: Randomized, Crossover, Head-to-Head, Double-Blinded Study (2024) Knitza J, Hasanaj R, Beyer J, Ganzer F, Slagman A, Bolanaki M, Napierala H, et al. Journal article CD19-CAR T-cell therapy induces deep tissue depletion of B cells (2024) Tur C, Eckstein M, Velden J, Rauber S, Bergmann C, Auth J, Bucci L, et al. Journal article Magnesium Disorders (2024) Manger B, Schett G Journal article, Letter Targeting cytokines in psoriatic arthritis (2024) Neurath L, Sticherling M, Schett G, Fagni F Journal article, Review article CAR T-cell perspectives in lupus – Authors' reply (2024) Schett G, Mackensen A, Mougiakakos D Journal article No difference in clinical parameters and drug retention in PsA patients receiving b/tsDMARD monotherapy versus combination with methotrexate: data from the RABBIT-SpA registry (2024) Regierer AC, Kiefer D, Schett G, Krause A, Weiß A, Sewerin P, Strangfeld A Journal article Neutrophil extracellular traps characterize caseating granulomas (2024) Zlatar L, Knopf J, Singh J, Wang H, Muñoz-Becerra M, Herrmann I, Chukwuanukwu R, et al. Journal article Nipocalimab, an anti-FcRn monoclonal antibody, in participants with moderate to severe active rheumatoid arthritis and inadequate response or intolerance to anti-TNF therapy: results from the phase 2a IRIS-RA study (2024) Taylor PC, Schett G, Huizinga TW, Wang Q, Ibrahim F, Zhou B, Liva SG, et al. Journal article